Wilson Sonsini Goodrich & Rosati represented SpyGlass in the transaction. SpyGlass Pharma announced the closing of $90 million in Series C financing. The financing, which was led...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here